Patents by Inventor Neil Boaz

Neil Boaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070244319
    Abstract: Bidentate phosphine-nitrogen ligands are disclosed which include a phosphine linked with a nitrogen heterocycle through a chiral ferrocene backbone. The ligands can include an imidazole or a dihydroimidazole linked to the ferrocene through the 2-position. Ligands can be prepared with or without additional chirality in the heterocycle. The ligands are useful for asymmetric catalysis, such as for palladium-catalyzed asymmetric allylation and ruthenium-catalyzed asymmetric transfer hydrogenation, affording products with high enantioselectivities.
    Type: Application
    Filed: April 18, 2006
    Publication date: October 18, 2007
    Inventors: Neil Boaz, James Ponasik
  • Publication number: 20060135804
    Abstract: This invention relates to novel, substantially enantiomerically pure tetradentate ligands comprised of two phosphines and two secondary amines. These species have been used as ligands for metal catalysts for asymmetric reactions and have demonstrated good enantioselectivity, in particular as ruthenium complexes for asymmetric hydrogenation. Also disclosed are methods for making the ligands, corresponding catalyst complexes, and processes employing the ligands and catalysts.
    Type: Application
    Filed: December 21, 2004
    Publication date: June 22, 2006
    Inventor: Neil Boaz
  • Publication number: 20050171082
    Abstract: The present invention relates to highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using therefor. The invention involves a multi-step synthesis to produce the lactam compounds. In one step of the reaction sequence, asymmetric hydrogenation of a lactam-enamide was performed to produce an intermediate that can ultimately be converted to a series of pharmaceutical compounds. The invention also contemplates the in situ synthesis of an intermediate of the multi-step synthesis, which provides economic advantages to the overall synthesis of the lactam compounds.
    Type: Application
    Filed: March 31, 2005
    Publication date: August 4, 2005
    Inventors: Neil Boaz, Sheryl Debenham